| pubmed-article:14746374 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14746374 | lifeskim:mentions | umls-concept:C1280551 | lld:lifeskim |
| pubmed-article:14746374 | lifeskim:mentions | umls-concept:C0017337 | lld:lifeskim |
| pubmed-article:14746374 | lifeskim:mentions | umls-concept:C0026882 | lld:lifeskim |
| pubmed-article:14746374 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:14746374 | lifeskim:mentions | umls-concept:C0671870 | lld:lifeskim |
| pubmed-article:14746374 | lifeskim:mentions | umls-concept:C1113688 | lld:lifeskim |
| pubmed-article:14746374 | lifeskim:mentions | umls-concept:C1415500 | lld:lifeskim |
| pubmed-article:14746374 | lifeskim:mentions | umls-concept:C0279033 | lld:lifeskim |
| pubmed-article:14746374 | lifeskim:mentions | umls-concept:C1550748 | lld:lifeskim |
| pubmed-article:14746374 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:14746374 | pubmed:dateCreated | 2004-1-28 | lld:pubmed |
| pubmed-article:14746374 | pubmed:abstractText | Using two different canine models of narcolepsy, we evaluated the therapeutic effects of hypocretin-1 on cataplexy and sleep. | lld:pubmed |
| pubmed-article:14746374 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14746374 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14746374 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14746374 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:14746374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14746374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14746374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14746374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14746374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14746374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14746374 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14746374 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14746374 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:14746374 | pubmed:issn | 0161-8105 | lld:pubmed |
| pubmed-article:14746374 | pubmed:author | pubmed-author:MignotEmmanue... | lld:pubmed |
| pubmed-article:14746374 | pubmed:author | pubmed-author:NishinoSeijiS | lld:pubmed |
| pubmed-article:14746374 | pubmed:author | pubmed-author:YoshidaYasush... | lld:pubmed |
| pubmed-article:14746374 | pubmed:author | pubmed-author:RipleyBethB | lld:pubmed |
| pubmed-article:14746374 | pubmed:author | pubmed-author:FujikiNobuhir... | lld:pubmed |
| pubmed-article:14746374 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14746374 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:14746374 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:14746374 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14746374 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14746374 | pubmed:pagination | 953-9 | lld:pubmed |
| pubmed-article:14746374 | pubmed:dateRevised | 2009-1-29 | lld:pubmed |
| pubmed-article:14746374 | pubmed:meshHeading | pubmed-meshheading:14746374... | lld:pubmed |
| pubmed-article:14746374 | pubmed:meshHeading | pubmed-meshheading:14746374... | lld:pubmed |
| pubmed-article:14746374 | pubmed:meshHeading | pubmed-meshheading:14746374... | lld:pubmed |
| pubmed-article:14746374 | pubmed:meshHeading | pubmed-meshheading:14746374... | lld:pubmed |
| pubmed-article:14746374 | pubmed:meshHeading | pubmed-meshheading:14746374... | lld:pubmed |
| pubmed-article:14746374 | pubmed:meshHeading | pubmed-meshheading:14746374... | lld:pubmed |
| pubmed-article:14746374 | pubmed:meshHeading | pubmed-meshheading:14746374... | lld:pubmed |
| pubmed-article:14746374 | pubmed:meshHeading | pubmed-meshheading:14746374... | lld:pubmed |
| pubmed-article:14746374 | pubmed:meshHeading | pubmed-meshheading:14746374... | lld:pubmed |
| pubmed-article:14746374 | pubmed:meshHeading | pubmed-meshheading:14746374... | lld:pubmed |
| pubmed-article:14746374 | pubmed:meshHeading | pubmed-meshheading:14746374... | lld:pubmed |
| pubmed-article:14746374 | pubmed:meshHeading | pubmed-meshheading:14746374... | lld:pubmed |
| pubmed-article:14746374 | pubmed:meshHeading | pubmed-meshheading:14746374... | lld:pubmed |
| pubmed-article:14746374 | pubmed:meshHeading | pubmed-meshheading:14746374... | lld:pubmed |
| pubmed-article:14746374 | pubmed:meshHeading | pubmed-meshheading:14746374... | lld:pubmed |
| pubmed-article:14746374 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:14746374 | pubmed:articleTitle | Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin-ligand-deficient narcoleptic dog. | lld:pubmed |
| pubmed-article:14746374 | pubmed:affiliation | Center for Narcolepsy, Stanford University School of Medicine, Palo Alto, CA 94304-5485, USA. | lld:pubmed |
| pubmed-article:14746374 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14746374 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14746374 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14746374 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14746374 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14746374 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14746374 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14746374 | lld:pubmed |
